Statement Of Comprehensive Income [Abstract]

Sopharma AD - Filing #6175083

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Statement of comprehensive income [abstract]
Profit (loss)	71 121 BGN	—	—	76 333 BGN	71 121 BGN	5 212 BGN	—	2 207 BGN	—	—	—	89 496 BGN	91 703 BGN	89 496 BGN
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans	—	—	—	1 498 BGN	—	—	—	—	—	—	—	—	25,000 BGN	—
Other comprehensive income that will not be reclassified to profit or loss, net of tax	—	—	—	441,000 BGN	—	—	—	—	—	—	—	—	9 086 BGN	—
Other comprehensive income that will be reclassified to profit or loss, net of tax	—	—	—	5 427 BGN	—	—	—	—	—	—	—	—	2 909 BGN	—
Other comprehensive income	6 011 BGN	892,000 BGN	1 047 BGN	5 868 BGN	1 355 BGN	143,000 BGN	5 427 BGN	479,000 BGN	355,000 BGN	3 367 BGN	9 485 BGN	12 474 BGN	11 995 BGN	23,000 BGN
Comprehensive income	65 110 BGN	892,000 BGN	1 047 BGN	70 465 BGN	72 476 BGN	5 355 BGN	5 427 BGN	1 728 BGN	355,000 BGN	3 367 BGN	9 485 BGN	101 970 BGN	103 698 BGN	89 473 BGN
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent	—	—	—	65 110 BGN	—	—	—	—	—	—	—	—	101 970 BGN	—
Comprehensive income, attributable to non-controlling interests	—	—	—	5 355 BGN	—	—	—	—	—	—	—	—	1 728 BGN	—